A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Waldenstrom Macroglobulinemia · Lymphoplasmacytic Lymphoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Dana Farber Cancer Institute (Data Collection and Specimen Analysis), Boston, Massachusetts, United States

    Contact: Study coordinator (Jorge Castillo, MD) · 617-632-4218
  • Beth Israel Deaconess Medical Center (Data Collection Only), Boston, Massachusetts, United States

    Contact: Study coordinator (Gottfried von Keudell, MD) · 617-667-9920
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (M. Lia Palomba, MD) · 646-608-3711
  • Memoral Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (M. Lia Palomba, MD) · 646-608-3711
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (M Lia Palomba, MD) · 646-608-3711
  • Memorial Sloan Kettering Suffolk - Commack, Commack, New York, United States

    Contact: Study coordinator (M. Lia Palomba, MD) · 646-608-3711
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (M. Lia Palomba, MD) · 646-608-3711
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (M. Lia Palomba, MD) · 646-608-3711
  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (M. Lia Palomba, MD) · 646-608-3711
מובילי המחקר
  • M. Lia Palomba, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center